Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years-Reference-Cited by-同舟云学术

Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years

Published:2016-01 Issue:1 Volume:48 Page:177-184
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Remenyi P.,Varga G.,Mikala G.,Reti M.,Gopcsa L.,Batai A.,Csukly Z.,Lengyel L.,Torbagyi E.,Barta A.,Fabian J.,Levai D.,Szombath G.,Andrikovics H.,Masszi T.

Funder

Nemzeti Kutatási Fejlesztési és Innovációs Hivatal

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference32 articles.

1. Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?;Mohty;Bone Marrow Transplant,2015

2. Approach to the treatment of multiple myeloma: a clash of philosophies;Rajkumar;Blood,2011

3. Curing myeloma at last: defining criteria and providing the evidence;Barlogie;Blood,2014

4. “Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?”;Moreau;Leuk Res,2012

5. Cost-effectiveness analysis of early vs late autologous stem cell transplantation in multiple myeloma;Pandya;Clin Transplant,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Cell Transplantation in Multiple Myeloma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapted Therapy;Cancers;2023-12-05

3. Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings;Cureus;2023-03-24

4. Multiple Myeloma: Impact of Time to Transplant on the Outcome;Clinical Lymphoma Myeloma and Leukemia;2022-09

5. Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019;British Journal of Haematology;2022-02-15